Cocrystal Pharma Inc expected to post a loss of 4  cents a share - Earnings Preview

Cocrystal Pharma

12/08/2022 15:57

* Cocrystal Pharma Inc  COCP.OQ   COCP.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 15
(estimated). 
    * The Bothell Washington-based  company is expected to
report
revenue of $83.33 thousand, according to the mean estimate from
3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Cocrystal Pharma
Inc is
for a loss of 4 cents per share. For the same quarter last year,
the company reported a loss of 4 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $4​, above​ its last closing price of $0.42. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.03       -0.03      -0.04     Missed  -14.3
 Dec. 31 2022  -0.04       -0.04      -0.04     Met     0
 Sep. 30 2021  -0.04       -0.04      -0.04     Met     0​
 Jun. 30 2021  -0.03       -0.03      -0.04     Missed  -14.3
 ​​Mar.        -0.05       -0.04      -0.04     Met     11.1
 31 2021                                                
 Dec. 31 2020              -0.04      -0.02     Beat    50​
 Sep. 30 2020              -0.05      -0.05     Met     0
 Jun. 30 2020  -0.04       -0.04      -0.07     Missed  -75
 This summary was machine generated August 12 at 14:57 GMT.  All
figures in US dollars  unless otherwise stated